Screening of a chemogenetic library unveils dual-stage antimalarials with low cytotoxicity
Torres, L.; Fishbaugher, M. E.; Lam, M.; Chao, A. T.; Martyn, C.; Pei, L.; Sengupta, D.; Dauphinais, M.; Gable, J. E.; Rao, S. P. S.; Renner, S.; Guiguemde, A. W.; Mikolajczak, S. A.; Harupa-Chung, A.; Mitchell, G.
Show abstract
The global effort to eradicate malaria requires the development of drugs with novel mechanisms of action and differentiated pharmacological profiles. Both liver and blood phases of Plasmodium infection are essential for disease progression and transmission, making them primary targets for therapeutic intervention. In this study, we established a dual-luciferase reporter assay to simultaneously assess Plasmodium berghei liver-stage development and host cell viability. Screening a library of bioactive small molecules with annotated human targets revealed several inhibitors with potent liver-stage activity and minimal cytotoxicity. Further profiling against P. falciparum asexual blood stages identified compounds with dual-stage activity, underscoring their potential utility for development as either prophylactic or therapeutic agents. Knowledge of their human targets will facilitate investigation into host- or parasite- directed antimalarial mechanisms, thereby accelerating both biological insight and rational drug development. Our findings constitute a valuable resource for research on malaria biology and the discovery of next-generation antimalarials.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Screening the Pathogen Box Compounds for Activity Against Plasmodium falciparum Sporozoite Motility 98%
- Activity of epigenetic inhibitors against Plasmodium falciparum asexual and sexual blood stages. 97%
- Effective Therapy Targeting Cytochrome bc1 Prevents Babesia Erythrocytic Development and Protects from Lethal Infection 96%
Similar papers in this journal
- Evolution of resistance in vitro reveals a novel mechanism of artemisinin activity in Toxoplasma gondii. 93%
- Post-infection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection 93%
- Direct Tests of Cytochrome Function in the Electron Transport Chain of Malaria Parasites 93%
Similar papers in this journal
- Accelerating antimalarial drug discovery with a new high-throughput screen for fast-killing compounds 96%
- High Throughput Repurposing Screen Reveals Compounds with Activity Against Toxoplasma gondii Bradyzoites 95%
- A pyridyl-furan series developed from Open Global Health Library blocks red blood cell invasion and protein trafficking in Plasmodium falciparum through potential inhibition of the parasites PI4KIIIb enzyme. 95%
Similar papers in this journal
- On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity. 97%
- Mechanistic Insights into Dual-Active Liver and Blood-Stage Antiplasmodials 96%
- Genomic and phenotypic characterization of experimentally selected resistant Leishmania donovani reveals a role for dynamin-1 like protein in the mechanism of resistance to a novel anti-leishmanial compound 95%
Similar papers in this journal
- Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway 96%
- Collateral sensitivity as a strategy to suppress resistance emergence: the challenge of diverse evolutionary pathways 94%
- Phosphatidylinositol 3-phosphate and Hsp70 protect Plasmodium falciparum from heat-induced cell death 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.